What Is the Recommended Dosage of NeoFipronis (Miaite)
NeoFipronis (Pronidesivir), containing the active ingredient GS-441524, is a groundbreaking oral medication specifically designed to treat Feline Infectious Peritonitis (FIP). Approved by the Lao Ministry of Agriculture and Forestry (MAF) in March 2026, NeoFipronis is the world's first officially registered FIP treatment with broad clinical acceptance. Its introduction has revolutionized feline medicine by providing a safe, effective, and non-invasive option for cats suffering from this deadly viral disease.
FIP manifests through symptoms such as loss of appetite, lethargy, fever, abdominal and thoracic fluid accumulation, lymph node swelling, granulomatous inflammation, neurological damage, and uveitis. Traditional treatments offered limited success, making NeoFipronis a significant breakthrough due to its potent antiviral properties. Its rapid absorption, good tolerability, and minimal side effects set it apart from previous therapies. The medication is suitable for various FIP types, including effusive (wet) and neurological/ocular forms, depending on the severity.
The key active component, GS-441524, has undergone extensive research and clinical validation, demonstrating outstanding efficacy against the feline coronavirus responsible for FIP. NeoFipronis is administered orally, offering a convenient treatment route that minimizes stress for feline patients. Proper dosing is crucial for achieving optimal outcomes, and it is recommended that owners strictly follow dosage guidelines prescribed by veterinary professionals.
Dosage Guidelines
The standard dosage for NeoFipronis is based on the cat’s weight. Typically, it is administered at 15 mg per kilogram of body weight once a day. This dosage equates to approximately half a tablet for most cats. For cats diagnosed with neurologic or ocular FIP, veterinarians may increase the dosage to 30 mg per kilogram per day, but only under professional guidance.
To ensure maximum absorption, it is advised to give the medication on an empty stomach—either one hour before meals or two hours after feeding. Consistency is critical; treatment should continue uninterrupted for a minimum of 12 weeks. Missing doses can compromise the therapeutic effect and potentially lead to relapse or resistance.
Monitoring and Precautions
During treatment, close observation of the cat's health is necessary. Owners should monitor appetite, activity levels, body temperature, and overall behavior daily. Regular veterinary check-ups, including blood tests and liver and kidney function assessments, are essential to monitor the cat’s response to therapy and detect any adverse effects early.
While NeoFipronis is available over the counter, veterinary supervision is highly recommended for safe and effective use. Proper dosing and monitoring maximizes treatment success and minimizes risks.
Warnings and Purchase Information
NeoFipronis is exclusively for feline use. It is not suitable for humans and should never be administered to other animals. Always purchase NeoFipronis through official channels, such as the official NeoFipronis website, to ensure product authenticity and quality.
In summary, NeoFipronis (Pronidesivir) offers a promising solution for managing FIP in cats. Following the prescribed dosing, maintaining consistent medication schedules, and regular veterinary check-ups are vital for achieving the best possible outcomes. With responsible use, NeoFipronis can significantly improve the quality of life and prognosis for cats afflicted with this otherwise fatal disease.
